Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 13.0 -1.81% -0.24
AXSM closed down 1.81 percent on Friday, March 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical AXSM trend table...

Date Alert Name Type % Chg
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Inside Day Range Contraction 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 New 52 Week Closing High Bullish -1.81%
Mar 21 Pocket Pivot Bullish Swing Setup -1.81%
Mar 21 Wide Range Bar Range Expansion -1.81%
Mar 21 Upper Bollinger Band Walk Strength -1.81%
Mar 21 Wide Bands Range Expansion -1.81%
Mar 21 Above Upper BB Strength -1.81%

Older signals for AXSM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Medicine Pain Organ Systems Alzheimer's Disease Pain Management Osteoarthritis Chronic Pain Central Nervous System Disorders Antidepressants Back Pain Perception Chronic Condition Treatment Resistant Depression
Is AXSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.24
52 Week Low 1.94
Average Volume 1,162,022
200-Day Moving Average 4.7323
50-Day Moving Average 9.2282
20-Day Moving Average 10.083
10-Day Moving Average 11.469
Average True Range 0.9961
ADX 38.37
+DI 37.37
-DI 7.6157
Chandelier Exit (Long, 3 ATRs ) 11.2517
Chandelier Exit (Short, 3 ATRs ) 10.6283
Upper Bollinger Band 13.4261
Lower Bollinger Band 6.7399
Percent B (%b) 0.94
BandWidth 66.311614
MACD Line 1.1351
MACD Signal Line 0.8004
MACD Histogram 0.3347
Fundamentals Value
Market Cap 306.93 Million
Num Shares 23.6 Million
EPS -1.45
Price-to-Earnings (P/E) Ratio -8.97
Price-to-Sales 0.00
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.44
Resistance 3 (R3) 14.44 13.95 14.20
Resistance 2 (R2) 13.95 13.59 13.96 14.12
Resistance 1 (R1) 13.48 13.36 13.24 13.48 14.04
Pivot Point 12.99 12.99 12.87 13.00 12.99
Support 1 (S1) 12.52 12.63 12.28 12.52 11.96
Support 2 (S2) 12.03 12.40 12.04 11.88
Support 3 (S3) 11.56 12.03 11.80
Support 4 (S4) 11.56